Patents by Inventor Simon P Fricker

Simon P Fricker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Increasing Blood Flow And/Or Promoting Tissue Regeneration
    Publication number: 20130095076
    Abstract: Methods for increasing blood flow and/or regenerating tissue using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred embodiments of such compounds are of the formula Z-linker-Z???(1).
    Type: Application
    Filed: July 5, 2012
    Publication date: April 18, 2013
    Applicant: Genzyme Corporation
    Inventors: Gary J. BRIDGER, Simon P. FRICKER
  • METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION
    Publication number: 20100035941
    Abstract: Methods for increasing blood flow and/or regenerating tissue using compounds which bind to the chemokine receptor CXCR4 are disclosed.
    Type: Application
    Filed: February 24, 2006
    Publication date: February 11, 2010
    Inventors: Gary J. Bridger, Simon P. Fricker
  • Use of rare earth compounds for the prevention of kidney stone disease
    Patent number: 7192609
    Abstract: Conditions such as kidney stones, which are characterized by undesired absorption of oxalate from the intestinal tract are conveniently treated using nontoxic salts of rare earth metal ions.
    Type: Grant
    Filed: April 22, 2002
    Date of Patent: March 20, 2007
    Assignee: Shire International Licensing B.V.
    Inventors: Michael J. Abrams, Gary J. Bridger, Simon P. Fricker, Stefan R. Idzan
  • Use of nitric oxide scavengers to modulate inflammation and matrix metalloproteinase activity
    Publication number: 20020193363
    Abstract: The present invention relates to modulating inflammation, or improving hemodynamic function, associated with trauma, such as that caused by surgery, through the administration of metal complexes, such as ruthenium nitric oxide scavengers. Further, the present invention relates to modulating matrix metalloproteinase activity also by administering such metal complexes. Modulation of the trauma or the metalloproteinase activity reduces tissue damage or causes a protective effect against organ damage.
    Type: Application
    Filed: December 7, 2001
    Publication date: December 19, 2002
    Inventors: Gary J. Bridger, Simon P. Fricker, Michael J. Abrams, Irvin Mayers
  • Use of rare earth compounds for the prevention of kidney stone disease
    Publication number: 20020155168
    Abstract: Conditions such as kidney stones, which are characterized by undesired absorption of oxalate from the intestinal tract are conveniently treated using nontoxic salts of rare earth metal ions.
    Type: Application
    Filed: April 22, 2002
    Publication date: October 24, 2002
    Inventors: Michael J. Abrams, Gary J. Bridger, Simon P. Fricker, Stefan R. Idzan
  • Pharmaceutical compositions comprising metal complexes
    Patent number: 6417182
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: July 9, 2002
    Assignee: AnorMED Inc.
    Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
  • Pharmaceutical compositions comprising metal complexes
    Publication number: 20020049190
    Abstract: A compound of the formula
    Type: Application
    Filed: March 17, 2000
    Publication date: April 25, 2002
    Inventors: Gary J. Bridger, Beth R. Cameron, Simon P. Fricker, Michael J. Abrams, Renato Skerlj, Ian Baird
  • Pharmaceutical compositions comprising metal complexes
    Publication number: 20020045611
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.
    Type: Application
    Filed: March 9, 2001
    Publication date: April 18, 2002
    Inventors: Michael J. Abrams, Simon P. Fricker, Barry A. Murrer, Owen John Vaughan
  • Pharmaceutical compositions comprising metal complexes
    Patent number: 6284752
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localised high concentration of nitric oxide in the body.
    Type: Grant
    Filed: October 19, 1998
    Date of Patent: September 4, 2001
    Assignee: AnorMED Inc.
    Inventors: Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
  • Pharmaceutical compositions comprising metal complexes
    Patent number: 5824673
    Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.
    Type: Grant
    Filed: February 26, 1996
    Date of Patent: October 20, 1998
    Assignee: Johnson Matthey Public Limted Company
    Inventors: Michael J. Abrams, Simon P. Fricker, Barry A. Murrer, Owen J. Vaughan